You have 9 free searches left this month | for more free features.

stage III gastric cancer

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adjuvant Huaier Granule Versus SOX in Gastric Cancer Patients

Not yet recruiting
  • Gastric Cancer
  • Huaier granule
  • +2 more
  • Wuhan, Hubei, China
    Wuhan Union Hospital
Aug 11, 2022

Collecting Blood Samples From and Without Cancer to Evaluate

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +61 more
  • Questionnaire Administration
  • Biospecimen Collection
  • (no location specified)
Apr 12, 2022

Gastric Cancer Stage II, Gastric Cancer Stage III Trial in Beijing (Toripalimab, oxaliplatin, capecitabine)

Recruiting
  • Gastric Cancer Stage II
  • Gastric Cancer Stage III
  • Beijing, Beijing, China
  • +1 more
Mar 9, 2022

Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,

Recruiting
  • Advanced Bile Duct Carcinoma
  • +33 more
  • Sacramento, California
  • +6 more
Aug 11, 2022

Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage I

Recruiting
  • Clinical Stage 0 Gastric Cancer AJCC v8
  • +27 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 5, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +38 more
  • Scottsdale, Arizona
  • +2 more
Aug 27, 2021

Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage

Active, not recruiting
  • Clinical Stage III Gastric Cancer AJCC v8
  • +7 more
  • Duarte, California
  • +30 more
Jan 7, 2023

Gastric Adenocarcinoma Trial in Saint-Herblain (Preoperative Chemotherapy, Surgery, Postoperative chemo)

Recruiting
  • Gastric Adenocarcinoma
  • Preoperative Chemotherapy
  • +2 more
  • Saint-Herblain, France
    Ico - Site Gauducheau - St Herblain
Mar 14, 2022

Metastatic Esophageal Carcinoma, Metastatic Gastric Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Esophageal Carcinoma
  • +12 more
  • Corona, California
  • +31 more
Aug 9, 2022

Gastric Cancer Trial in Gyeonggi-do (Oxaliplatin, Capecitabine)

Recruiting
  • Gastric Cancer
  • Gyeonggi-do, Korea, Republic of
    Hallym University Medical Center
Feb 4, 2022

Gastric Cancer Trial in Guangzhou (Docetaxel, Oxaliplatin)

Recruiting
  • Gastric Cancer
  • Guangzhou, China
    Sixth Affiliated Hospital of Sun Yat-sen University
May 26, 2021

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Locally Advanced Gastrointestinal Stromal Tumor, Locally Advanced Sarcoma, Metastatic Gastrointestinal Stromal Tumor Trial in

Recruiting
  • Locally Advanced Gastrointestinal Stromal Tumor
  • +7 more
  • Biopsy
  • +4 more
  • Duarte, California
  • +17 more
Feb 2, 2023

Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8, Clinical Stage III Gastric Cancer AJCC v8

Recruiting
  • Clinical Stage I Gastric Cancer AJCC v8
  • +15 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 19, 2020

Gastric Carcinoma Stage IV, Esophagogastric Junction Adenocarcinoma Stage IV Trial in Moscow (Irinotecan, Oxaliplatin, 5-FU)

Recruiting
  • Gastric Carcinoma Stage IV
  • Esophagogastric Junction Adenocarcinoma Stage IV
  • Moscow, Russian Federation
    Blokhin's Russian Cancer Research Center
Apr 11, 2021

Gastric Cancer Stage IIIB-IIIC Trial in Shanghai (Pembrolizumab + SOX)

Recruiting
  • Gastric Cancer Stage IIIB-IIIC
  • Pembrolizumab + SOX
  • Shanghai, Shanghai, China
    Ruijin Hospital
Sep 7, 2023

Gastric Cancer Stage III Trial in Shanghai (Camrelizumab, S-1, Docetaxel)

Recruiting
  • Gastric Cancer Stage III
  • Shanghai, China
    Ethics Committee of Renji Hospital, School of Medicine, Shanghai
Apr 16, 2020

Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III

Unknown status
  • Advanced Gastroesophageal Junction Adenocarcinoma
  • +24 more
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Jun 18, 2020

Serplulimab,Gastric Cancer, Adjuvant Therapy Trial in Shanghai (Serplulimab, Docetaxel, S1)

Recruiting
  • Serplulimab,Gastric Cancer, Adjuvant Therapy
  • Shanghai, China
    Zhang Zizhen
Mar 3, 2023

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in

Terminated
  • Adenocarcinoma of the Esophagus
  • +13 more
  • oblimersen sodium
  • +2 more
  • Bronx, New York
    Montefiore Medical Center
Jan 29, 2021

Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, Clinical Stage IVB Gastric Cancer AJCC v8

Recruiting
  • Clinical Stage IV Gastric Cancer AJCC v8
  • +26 more
  • Biopsy
  • +10 more
  • Duarte, California
  • +2 more
Jan 25, 2023

Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in ZhengZhou (Cadonilimab

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • Cadonilimab (®), a PD-1/CTLA-4 bi-specific antibody
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jun 18, 2023

Malignant Female Reproductive System Tumor, Stage III Cervical Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8 Trial in Duarte

Not yet recruiting
  • Malignant Female Reproductive System Neoplasm
  • +10 more
  • Discussion
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Mar 24, 2023

Colorectal Cancer Trial in Taipei (Colectomy with NOSE procedure)

Recruiting
  • Colorectal Cancer
  • Colectomy with NOSE procedure
  • Taipei, Taiwan
    National Taiwan University Hospital
Jul 23, 2023

Lung Cancer Stage III Trial (Almonertinib)

Not yet recruiting
  • Lung Cancer Stage III
  • (no location specified)
Aug 8, 2023